Abstract:Lung transplant recipients frequently encounter immune-related complications, including chronic lung allograft dysfunction (CLAD). Monitoring immune cells within the lung microenvironment is pivotal for optimizing post-transplant outcomes. This study examined the proportion of T cell subsets in paired bronchoalveolar lavage (BAL) and peripheral PBMC comparing healthy (n = 4) and lung transplantation patients (n = 6, no CLAD and n = 14 CLAD) using 14-color flow cytometry. CD4+ T cell proportions were reduced in CD3 cells in both PBMC and BAL, and positive correlations were discerned between T cell populations in peripheral PBMC and BAL, suggesting the prospect of employing less invasive PBMC sampling as a means of monitoring lung T cells. Furthermore, regulatory T cells (Tregs) were enriched in BAL when compared to peripheral PBMC for transplant recipients. A parallel positive correlation emerged between Treg proportions in BAL and peripheral PBMC, underscoring potential avenues for monitoring lung Tregs. Finally, the most promising biomarker was the Teff (CD8+Granzyme B+)–Treg ratio, which was higher in both the PBMC and BAL of transplant recipients compared to healthy individuals, and increased in the patients with CLAD compared to no CLAD and healthy patients. Conclusions: Distinct T cell profiles in BAL and peripheral PBMC underscore the significance of localized immune monitoring in lung transplantation. The Teff (CD8+granzyme B+)–Treg ratio, particularly within the context of CLAD, emerges as a promising blood and BAL biomarker reflective of inflammation and transplant-related complications. These findings emphasize the imperative need for personalized immune monitoring strategies that tailored to address the unique immunological milieu in post-transplant lungs.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is: in lung transplant recipients, by analyzing T - cell subsets in bronchoalveolar lavage fluid (BAL) and peripheral blood mononuclear cells (PBMC), to reveal the changes in the immune environment after transplantation, especially the immune characteristics related to chronic lung allograft dysfunction (CLAD). Specifically, the study aims to: 1. **Compare the differences in T - cell subsets between healthy individuals and lung transplant patients**: Analyze the proportion of CD4+ and CD8+ T - cells and their subsets (such as regulatory T - cells (Tregs), memory T - cells (Tmem) and effector T - cells (Teffs)) by multicolor flow cytometry, and explore the local and systemic changes in the immune system after transplantation. 2. **Evaluate the correlations between different T - cell subsets**: Study whether there are correlations in the proportion of T - cell subsets in BAL and PBMC, in order to evaluate whether less - invasive PBMC sampling can be used to monitor the changes of lung T - cells. 3. **Identify potential biomarkers**: Pay special attention to the ratio of effector T - cells (Teffs, such as CD8+ Granzyme B+ T - cells) to regulatory T - cells (Tregs) (Teff - Treg ratio), to determine its feasibility as a potential blood and BAL biomarker for CLAD - related inflammation and transplantation complications. ### Main findings - **Changes in the proportion of T - cell subsets**: In lung transplant patients, the proportion of CD4+ T - cells decreases, while the proportion of effector T - cells (especially CD8+ Granzyme B+ T - cells) increases, especially more obvious in CLAD patients. - **Tregs are enriched in BAL**: Compared with peripheral blood, the proportion of Tregs in BAL is higher, and there is a positive correlation between the proportion of Tregs in BAL and PBMC. - **Teff - Treg ratio as a biomarker**: The Teff - Treg ratio is significantly higher in lung transplant patients than in healthy individuals, and is further increased in CLAD patients, suggesting that this ratio may be an important indicator reflecting the immune state after transplantation. ### Conclusion This study shows that the immune environment after lung transplantation has significant local characteristics, especially in CLAD patients. By monitoring T - cell subsets, especially the Teff - Treg ratio, valuable clues can be provided for personalized immune monitoring, which is helpful for optimizing the management and treatment strategies after transplantation.

Insights from T Cell Profiling in BAL and PBMC